Nanoparticle-Induced Immunoresponsive Correction
and Redirection of Fat Accumulation
The
Solutions: NIIC and RFA
NIIC The video below describes how
NIIC will cure Type I diabetes.
Attaching nanoparticles to islet antigens modifies the
structure of the molecule. When these modified antigens are
injected into the spleen, macrophages engulf them, but do not
initiate an immune response. The modified antigens are presented
on the surface, and T-cells bind to them. Thus, the T-cells are
“fooled” into thinking that the islet antigens have mutated, and
will search for them, but will not find them in the body’s
cells. Thus, immunoresponsive correction in Type I diabetes is
achieved. This mechanism is one of
two explanations for the reason the treatment works. The second
explanation is that the immune system will recognize the
nanoparticles as part of the body because of its
biodegradability, thus rewiring the immune system to not attack
islet cells.
RFA
The video below describes how RFA will cure Type II
diabetes.
RFA is a drug that redirects fat accumulation away from the
heart and muscles helps make insulin more available to cells in
those areas. Coupling this technique with a healthy lifestyle
will eliminate Type II diabetes.